Nurix Therapeutics Cash Flow Statement (2019-2025) | NRIX

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Aug2019 Nov2019 Feb2020 May2020 Aug2020 Nov2020 Feb2021 May2021 Aug2021 Nov2021 Feb2022 May2022 Aug2022 Nov2022 Feb2023 May2023 Aug2023 Nov2023 Feb2024 May2024 Aug2024 Nov2024 Feb2025 May2025 Aug2025
Operating Activities
Net Income -2.43M-13.52M-12.39M7.58M-18.52M-19.90M-24.27M-26.38M-28.84M-37.69M-42.53M-45.40M-45.71M-46.72M-40.73M-24.28M-36.98M-41.96M-41.52M-44.55M-48.96M-58.55M-56.35M-43.46M-86.42M
Share-based Compensation 0.17M0.18M0.47M1.11M2.54M2.70M3.94M4.31M4.84M6.07M6.78M6.99M8.30M8.48M8.72M8.45M8.02M7.82M8.85M8.75M8.51M8.72M10.38M9.77M
Gains from Sales and Divestitures 0.01M0.03M
Gains from Investment Securities 3.46M5.10M5.14M2.82M-12.80M6.52M-0.20M5.27M0.02M0.02M0.03M23.92M0.00M1.30M2.81M5.79M
Non-cash Items 0.76M12.50M141.25M49.70M48.90M54.90M57.90M75.20M68.20M85.90M
Cash from Operations -12.75M40.97M-14.43M-6.14M-20.48M8.05M-31.54M-29.97M-30.91M-42.63M-32.91M-46.31M-37.95M-48.45M-18.47M-41.13M26.69M-41.95M-39.70M-42.18M-48.75M-61.09M-63.16M-57.38M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles -0.01M-0.04M-0.08M-0.14M0.74M0.83M0.86M0.85M1.26M1.35M1.43M1.42M1.43M1.44M1.43M1.82M1.93M2.16M3.71M3.49M3.56M2.70M2.20M
Depreciation & Amortization (CF) 0.60M0.59M0.49M0.50M0.60M0.66M0.64M0.60M0.70M0.77M0.99M1.30M1.50M1.62M1.75M1.90M1.95M1.93M2.04M2.33M2.39M2.55M2.35M2.24M2.03M
Change in Working Capital
Change in Receivables 2.00M-2.00M
Change in Account Payables 0.04M0.30M1.45M-1.14M0.63M0.90M1.22M-1.39M0.86M-0.10M1.85M-0.76M-0.90M0.40M-2.24M-1.20M4.65M-0.93M-2.54M1.09M7.58M-3.21M-2.68M2.23M
Change in Accured Expenses 1.61M1.43M-3.32M2.46M1.70M2.17M-2.86M3.53M3.38M-3.32M6.14M1.36M3.30M-6.91M2.26M4.70M3.08M3.59M-6.84M6.04M9.02M6.94M-7.01M6.34M
Change in Taxes -15.73M-0.01M0.14M-0.84M-2.94M
Investing Activities
Capital Expenditures 0.95M0.36M1.61M1.67M0.91M0.84M2.09M1.86M0.86M3.47M2.79M3.42M2.56M2.28M1.08M2.46M2.58M2.88M1.94M2.35M2.10M3.48M2.67M2.71M
Change in Acquisitions & Divestments 5.02M10.50M46.20M73.48M64.21M55.02M58.75M62.81M72.77M84.48M40.99M105.62M99.82M76.61M93.20M95.98M110.83M159.50M139.20M142.34M156.19M
Cash from Investing Activities -4.37M-19.42M-2.34M-108.08M-124.56M-2.39M-57.11M-12.23M-36.52M40.03M-4.76M-63.08M55.01M16.07M43.83M22.77M-14.37M35.51M-131.07M-21.34M-140.82M25.53M71.50M50.48M
Financing Activities
Change in Capital Stock
Shares Issued 0.08M0.05M0.13M219.12M-1.15M1.04M-0.04M1.06M-0.18M1.45M0.78M1.27M48.50M42.00M93.60M1.25M0.98M
Misc.
Cash from Financing Activities 0.08M0.05M119.68M220.42M-1.13M1.36M150.47M1.55M0.50M1.49M0.43M115.41M-0.14M1.48M0.03M1.70M0.01M1.62M237.75M45.77M200.52M1.47M0.01M1.16M
Change in Cash -17.03M21.59M102.92M106.20M-146.17M7.03M61.83M-40.65M-66.93M-1.11M-37.25M6.02M16.92M-30.90M25.39M-16.65M12.32M-4.81M66.98M-17.75M10.95M-34.08M8.34M-5.75M
Beginning Cash Balance 51.85M51.85M-21.59M-102.92M159.33M265.53M119.36M126.38M188.09M147.44M79.89M78.78M41.53M47.56M64.47M33.57M58.96M42.30M54.63M49.81M116.79M99.04M110.00M75.92M84.19M
Free Cash Flow -13.70M40.61M-16.04M-7.81M-21.39M7.21M-33.63M-31.84M-31.77M-46.10M-35.70M-49.73M-40.52M-50.73M-19.55M-43.59M24.10M-44.84M-41.64M-44.52M-50.86M-64.57M-65.84M-60.10M
Net Cash Flow -17.03M21.59M102.92M106.20M-146.17M7.03M61.83M-40.65M-66.93M-1.11M-37.25M6.02M16.92M-30.90M25.39M-16.65M12.32M-4.81M66.98M-17.75M10.95M-34.08M8.34M-5.75M